E1639. Role of Noncontrast MRI for Acute Abdominopelvic Pain in Pregnancy
  1. Nikolas Brozovich; Medical College of Georgia- Augusta University
  2. Jigarkumar Rangunwala ; University of Mississippi Medical Center
  3. Manohar Roda ; University of Mississippi Medical Center
  4. Thomas Estes; Medical College of Georgia- Augusta University
  5. Pardeep Mittal ; Medical College of Georgia- Augusta University
Multiple studies have shown the advantages of Magnetic Resonance Imaging (MRI) in the evaluation of acute abdominopelvic pathology during pregnancy. Due to concerns involving ionizing radiation exposure from Computed Tomography(CT) imaging, MRI has gained increased popularity. Our presentation will highlight how MRI can be crucial in the diagnosis of acute abdominopelvic pain during pregnancy. We will review focused MRI protocols and discuss strengths and limitations of key sequences. Furthermore, a guided case collection of challenging pathologies will be included.

Educational Goals / Teaching Points
Our exhibit will review the indications and risk/benefit analysis of MRI during pregnancy. MRI techniques and its clinical case-based applications will be discussed.

Key Anatomic/Physiologic Issues and Imaging Findings/Techniques
This exhibit covers acute abdomen MRI protocols. We will review breath-hold fast sequences such as single-shot T2-wighted imaging, T2-wighted imaging with fat saturation, T1-weighted 4-point Dixon, true fast imaging with steady state precession (tru-FISP), Diffusion-Weighted Imaging(DWI), and magnetic resonance cholangiopancreatography(MRCP). A case-based review will be provided by organ system to include hepatobiliary, pancreatic, genitourinary, bowel, splenic, obstetrics, and gynecological images.

MRI is a valuable tool in pregnant patients with acute abdominopelvic pain by providing accurate and definite diagnoses without intravenous/oral contrast administration or ionizing radiation. Furthermore, by utilizing faster sequences and abbreviated protocols, MRI can be tailored to help mitigate theoretical risks to the embryo/fetus of a pregnant patient.